|
WAC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.93519994368319E-10 |
| Normal-vs-Stage3 |
2.22044604925031E-16 |
| Normal-vs-Stage4 |
1.75448544581513E-12 |
| Stage1-vs-Stage2 |
9.712400E-01 |
| Stage1-vs-Stage3 |
2.052000E-01 |
| Stage1-vs-Stage4 |
1.562000E-01 |
| Stage2-vs-Stage3 |
3.716800E-01 |
| Stage2-vs-Stage4 |
2.436000E-01 |
| Stage3-vs-Stage4 |
6.707000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.41790000002451E-06 |
| Normal-vs-Asian |
1.04229957997859E-11 |
| Caucasian-vs-AfricanAmerican |
2.139800E-01 |
| Caucasian-vs-Asian |
7.764200E-01 |
| AfricanAmerican-vs-Asian |
3.464000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.792200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62625468647093E-12 |
| Normal-vs-Age(81-100Yrs) |
5.88149999999343E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.206200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.882200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.200400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.052000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.894800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.431200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.690400E-02 |
| Classical-VS-Follicular |
9.197000E-01 |
| Classical-VS-Other |
5.862600E-01 |
| Classical-VS-Normal |
3.11828340926468E-12 |
| Tall-VS-Follicular |
9.604300E-02 |
| Tall-VS-Other |
7.432200E-01 |
| Tall-VS-Normal |
1.63058455626697E-12 |
| Follicular-VS-Other |
6.440600E-01 |
| Follicular-VS-Normal |
5.59360335827819E-11 |
| Other-VS-Normal |
6.354700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.1863400806742E-14 |
| N0-vs-N1 |
7.760100E-02 |
|
|
